IL6 and chronic obstructive pulmonary disease: In this study, MP ameliorated in vitro COPD injury by increasing the levels of SOD and GSH-Px and decreasing the levels of MDA, TNF-α, IL-6 and IL-1β to reduce the inflammatory response and oxidative stress in CSE.